Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Higgins

Showing results (731-740 of 837) with videos related to

Pageof 84
Sort By:
Alimentary Pharmacology & Therapeutics|April 17, 2014
Letter: biological drugs for inducing remission in ulcerative colitis - authors' replyR W Stidham, T C H Lee, P D R Higgins, et al.
Crohn'S & Colitis 360|March 31, 2023
Efficacy and Safety of Advanced Therapies for Moderately to Severely Active Ulcerative Colitis at Induction and Maintenance: An Indirect Treatment Comparison Using Bayesian Network Meta-analysisRemo Panaccione, Eric B Collins, Gil Y Melmed, et al.
European Journal of Gastroenterology & Hepatology|August 18, 2020
Mapping the relationships between inflammatory bowel disease and comorbid diagnoses to identify disease associationsAkbar K Waljee, Mohamed Noureldin, Jeffrey A Berinstein, et al.
Alimentary Pharmacology & Therapeutics|May 28, 2011
Review article: defining remission in ulcerative colitisS P L Travis, P D R Higgins, T Orchard, et al.
Crohn'S & Colitis 360|February 5, 2024
Association of Bowel Urgency With Quality-of-Life Measures in Patients With Moderately-to-Severely Active Ulcerative Colitis: Results From Phase 3 LUCENT-1 (Induction) and LUCENT-2 (Maintenance) StudiesMillie D Long, Stefan Schreiber, Toshifumi Hibi, et al.
Nature|January 9, 2019
Disruption of the Orion molecular core 1 by wind from the massive star θ<sup>1</sup> Orionis CC Pabst, R Higgins, J R Goicoechea, et al.
Plos One|December 27, 2022
Understanding clinician connections to inform efforts to promote high-quality inflammatory bowel disease careShirley Cohen-Mekelburg, Tony Van, Xianshi Yu, et al.
Journal of Patient-Reported Outcomes|June 12, 2018
Development and validation of the Ulcerative Colitis patient-reported outcomes signs and symptoms (UC-pro/SS) diaryPeter D R Higgins, Gale Harding, Dennis A Revicki, et al.
BMC Cancer|July 5, 2003
Outcome of ATP-based tumor chemosensitivity assay directed chemotherapy in heavily pre-treated recurrent ovarian carcinomaSanjay Sharma, Michael H Neale, Federica Di Nicolantonio, et al.
Leukemia Research|August 19, 2003
Comparison of interphase FISH and metaphase cytogenetics to study myelodysplastic syndrome: an Eastern Cooperative Oncology Group (ECOG) studyAthena M Cherry, Stephanie R Brockman, Sarah F Paternoster, et al.
Pageof 84

Showing results (731-740 of 837) with videos related to

Sort By:
Pageof 84
Alimentary Pharmacology & Therapeutics|April 17, 2014
Letter: biological drugs for inducing remission in ulcerative colitis - authors' replyR W Stidham, T C H Lee, P D R Higgins, et al.
Crohn'S & Colitis 360|March 31, 2023
Efficacy and Safety of Advanced Therapies for Moderately to Severely Active Ulcerative Colitis at Induction and Maintenance: An Indirect Treatment Comparison Using Bayesian Network Meta-analysisRemo Panaccione, Eric B Collins, Gil Y Melmed, et al.
European Journal of Gastroenterology & Hepatology|August 18, 2020
Mapping the relationships between inflammatory bowel disease and comorbid diagnoses to identify disease associationsAkbar K Waljee, Mohamed Noureldin, Jeffrey A Berinstein, et al.
Alimentary Pharmacology & Therapeutics|May 28, 2011
Review article: defining remission in ulcerative colitisS P L Travis, P D R Higgins, T Orchard, et al.
Crohn'S & Colitis 360|February 5, 2024
Association of Bowel Urgency With Quality-of-Life Measures in Patients With Moderately-to-Severely Active Ulcerative Colitis: Results From Phase 3 LUCENT-1 (Induction) and LUCENT-2 (Maintenance) StudiesMillie D Long, Stefan Schreiber, Toshifumi Hibi, et al.
Nature|January 9, 2019
Disruption of the Orion molecular core 1 by wind from the massive star θ<sup>1</sup> Orionis CC Pabst, R Higgins, J R Goicoechea, et al.
Plos One|December 27, 2022
Understanding clinician connections to inform efforts to promote high-quality inflammatory bowel disease careShirley Cohen-Mekelburg, Tony Van, Xianshi Yu, et al.
Journal of Patient-Reported Outcomes|June 12, 2018
Development and validation of the Ulcerative Colitis patient-reported outcomes signs and symptoms (UC-pro/SS) diaryPeter D R Higgins, Gale Harding, Dennis A Revicki, et al.
BMC Cancer|July 5, 2003
Outcome of ATP-based tumor chemosensitivity assay directed chemotherapy in heavily pre-treated recurrent ovarian carcinomaSanjay Sharma, Michael H Neale, Federica Di Nicolantonio, et al.
Leukemia Research|August 19, 2003
Comparison of interphase FISH and metaphase cytogenetics to study myelodysplastic syndrome: an Eastern Cooperative Oncology Group (ECOG) studyAthena M Cherry, Stephanie R Brockman, Sarah F Paternoster, et al.
Pageof 84